Cancer-Associated DAXX Mutations Reveal a Critical Role for ATRX Localization in ALT Suppression.

Area of Science:

• Cellular biology
• Genetics
• Cancer research

Background:

• Genome stability relies on telomere maintenance, with most tumors using telomerase, but a subset using alternative lengthening of telomeres (ALT).
• Alternative lengthening of telomeres (ALT) is linked to mutations in the ATRX/DAXX/H3.3 histone chaperone complex, which deposits histone variant H3.3 at telomeres.
• The specific role of DAXX in suppressing ALT and the impact of its disease-associated mutations remain incompletely understood.

Purpose of the Study:

• To investigate the role of DAXX in suppressing alternative lengthening of telomeres (ALT).
• To determine which disease-associated DAXX mutations fail to suppress ALT.
• To elucidate the mechanism by which DAXX suppresses ALT.

Main Methods:

• Utilized the G292 cell line, which has wild-type ATRX but a fused DAXX.
• Restored wild-type DAXX in G292 cells to observe its effect on ATRX localization and ALT.
• Tested disease-associated DAXX missense variants for their ability to suppress ALT in this model system.

Main Results:

• Restoration of wild-type DAXX in G292 cells led to ATRX localization and abrogated ALT.
• Missense mutations in DAXX's ATRX binding domain, histone binding domain, and SUMO interaction motif reduced its ability to suppress ALT.
• Mutations in the DAXX histone binding domain unexpectedly caused a failure in ATRX localization.

Conclusions:

• DAXX plays a critical role in suppressing alternative lengthening of telomeres (ALT).
• A key function of DAXX in ALT suppression is facilitating the localization of ATRX to nuclear foci.
• Disease-associated DAXX mutations, particularly those affecting the histone binding domain, impair ATRX localization and ALT suppression, highlighting DAXX's importance in maintaining genome stability.